Show simple item record

dc.contributor.authorMcCabe, J
dc.contributor.authorWilcock, M
dc.contributor.authorAtkinson, K
dc.contributor.authorLaugharne, Richard
dc.contributor.authorShankar, Rohit
dc.date.accessioned2021-05-23T08:51:47Z
dc.date.available2021-05-23T08:51:47Z
dc.date.issued2020-07
dc.identifier.issn2056-4724
dc.identifier.issn2056-4724
dc.identifier.othere64
dc.identifier.urihttp://hdl.handle.net/10026.1/17185
dc.description.abstract

<jats:sec id="S2056472420000484_sec_a1" sec-type="other"> <jats:title>Background</jats:title> <jats:p>There has been a recent rise in antidepressant prescriptions. After the episode for which it was prescribed, the patient should ideally be supported in withdrawing the medication. There is increasing evidence for withdrawal symptoms (sometimes called discontinuation symptoms) occurring on ceasing treatment, sometimes having severe or prolonged effects.</jats:p> </jats:sec> <jats:sec id="S2056472420000484_sec_a2" sec-type="other"> <jats:title>Aims</jats:title> <jats:p>To identify and compare current knowledge, attitudes and practices of general practitioners (GPs) and psychiatrists in Cornwall, UK, concerning antidepressant withdrawal symptoms.</jats:p> </jats:sec> <jats:sec id="S2056472420000484_sec_a3" sec-type="methods"> <jats:title>Method</jats:title> <jats:p>Questions about withdrawal symptoms and management were asked of GPs and psychiatrists in a multiple-choice cross-sectional study co-designed with a lived experience expert.</jats:p> </jats:sec> <jats:sec id="S2056472420000484_sec_a4" sec-type="results"> <jats:title>Results</jats:title> <jats:p>Psychiatrists thought that withdrawal symptoms were more severe than GPs did (<jats:italic>P</jats:italic> = 0.003); 53% (22/42) of GPs and 69% (18/26) of psychiatrists thought that withdrawal symptoms typically last between 1 and 4 weeks, although there was a wide range of answers given; 35% (9/26) of psychiatrists but no GPs identified a pharmacist as someone they may use to help manage antidepressant withdrawal. About three-quarters of respondents claimed they usually or always informed patients of potential withdrawal symptoms when they started a patient on antidepressants, but patient surveys say only 1% are warned.</jats:p> </jats:sec> <jats:sec id="S2056472420000484_sec_a5" sec-type="conclusions"> <jats:title>Conclusions</jats:title> <jats:p>Psychiatrists and GPs need to effectively warn patients of potential withdrawal effects. Community pharmacists might be useful in supporting GP-managed antidepressant withdrawal. The wide variation in responses to most questions posed to participants reflects the variation in results of research on the topic. This highlights a need for more reproducible studies to be carried out on antidepressant withdrawal, which could inform future guidelines.</jats:p> </jats:sec>

dc.format.extente64-
dc.format.mediumElectronic
dc.languageen
dc.language.isoeng
dc.publisherRoyal College of Psychiatrists
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAntidepressants
dc.subjectwithdrawal side-effects
dc.subjectpublic mental health
dc.subjectpublic opinion
dc.titleGeneral practitioners’ and psychiatrists’ attitudes towards antidepressant withdrawal
dc.typejournal-article
dc.typeJournal Article
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000542770700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue4
plymouth.volume6
plymouth.publication-statusPublished
plymouth.journalBJPsych Open
dc.identifier.doi10.1192/bjo.2020.48
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Users by role
dc.publisher.placeEngland
dc.identifier.eissn2056-4724
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1192/bjo.2020.48
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV